Alphabet (GOOGL) – A play on potential competition from new chat bots, like ChatGPT and OpenAI. Analysts at Morgan Stanley Wednesday morning issued a research note which questioned possible negative impacts on Google searches from new artificial intelligence/natural language queries. The analysts suggested that every 10% of Google Search queries migrated toward AI/natural language queries could be a 150 basis point drag on the company’s 2025 operating margins.
Chewy (CHWY) – A top pick for 2023 by analysts at Needham. The firm’s $55 price target represented potential upside of about 36% from where shares of Chewy traded as of Wednesday morning.
Intuitive Surgical (ISRG) – A play on robotics for surgery. Execs at the company will present at the top healthcare conference Wednesday, the JP Morgan Healthcare conference. Execs presenting at this conference will often times gives material updates about company operations which could move stocks.
BrainStorm Cell Therapeutics (BCLI) – A play on an FDA date Wednesday. The company has an FDA Type-A meeting planned for today following BrainStorm’s previous Phase 3 trial for its amytrophic lateral sclerosis (ALS) candidate which failed to meet the primary endpoint.
Broadwind Energy (BWEN) – A play on wind power. One of Wednesday’s momentum names. Shares were up more than 50% following news of $175 million in new orders for wind-power towers from a turbine manufacturer.